More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade
The combination of antiangiogenic and immune checkpoint inhibitor (ICI) treatment is active in solid tumors, but the mechanism of response remains unclear. In this issue of Immunity, Benmebarek et al. show that anti-vascular endothelial growth factor e…